MedTrace Logo MedTrace
Clinical Trials News Drugs Diseases Companies About

REGENXBIO Inc.

  1. Home
  2. Companies
  3. REGENXBIO Inc.
  4. Clinical Trials

Clinical Trials Related to REGENXBIO Inc.

Related studies linked through entity extraction aliases.

NCT03580083

RGX-111 Gene Therapy in Patients With MPS I

Status
SUSPENDED
Phase
PHASE1/PHASE2

NCT03566043

CAMPSIITE™ RGX-121 Gene Therapy in Subjects With MPS II (Hunter Syndrome)

Status
ACTIVE_NOT_RECRUITING
Phase
PHASE2/PHASE3

NCT03529786

Mucopolysaccharidosis Type II Natural History

Status
COMPLETED
Phase
N/A

NCT03066258

Safety and Tolerability of RGX-314 (Investigational Product) Gene Therapy for Neovascular AMD Trial

Status
COMPLETED
Phase
PHASE1/PHASE2

NCT02651675

A Gene Therapy Study for Homozygous Familial Hypercholesterolemia (HoFH)

Status
TERMINATED
Phase
PHASE1/PHASE2
Previous

Next

Clinical Trials

Explore studies by the year of their last update.

  • 2026
  • 2025
  • 2024
  • 2023
  • 2022
  • 2021
  • 2020
  • 2019
  • 2018
  • 2017
  • 2016
  • 2015
  • 2014
  • 2013
  • 2012
  • 2011
  • 2010
  • 2009
  • 2008
  • 2007
  • 2006
  • 2005

News & Analysis

Latest news and insights on clinical trials and medical research.

Browse All News →
MedTrace Logo MedTrace
About Privacy Policy Terms of Service Medical Disclaimer

© 2026 MedTrace.
Open-access medical & pharmaceutical data intelligence.